SKI Market

Indian Indices

Sensex

83,277.15 650.39
( 0.79%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

56,974.47 32.50
(0.06%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01011

189.4317315

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

48.64

1001.68

EPS(TTM)

Face Value()

Div & Yield %

24.92

0.16

Back

titan biotech ltd

Titan Biotech consolidated net profit rises 15.82% in the September 2025 quarter

Nov 12,2025

Net profit of Titan Biotech rose 15.82% to Rs 7.76 crore in the quarter ended September 2025 as against Rs 6.70 crore during the previous quarter ended September 2024. Sales rose 36.25% to Rs 54.35 crore in the quarter ended September 2025 as against Rs 39.89 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	54.35	39.89	36
OPM %	17.17	19.45	-
PBDT	10.43	7.81	34
PBT	9.22	6.72	37
NP	7.76	6.70	16

83,277.15 650.39 ( 0.79%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

56,974.47 32.50 (0.06%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)